top of page
OUR DISCOVERY ENGINE
Single-Cell Sequencing & Immunoprofiling
Understand the tumor → Identify targets → Uncover immune signatures → Prioritize therapeutic opportunities
Patient/Tumor
Samples
Single-Cell Sequencing & Immunoprofiling
Target & Immune Signature Discovery
Therapeutic Opportunity Prioritization
Therapeutic
Concepts
OUR PROTOTYPE PORTFOLIO
Multiple Therapeutic Paths. One Goal.
We are developing and exploring innovative therapeutic prototypes across the following modalities.
IMMUNE ENGINEERING
Engineering immune-based therapeutic concepts to restore and enhance anti-tumor immunity.
ANTIBODY-DRUG CONJUGATES
Designing targeted antibody conjugates that deliver potent payloads selectively to cancer cells.
NANO
PLATFORMS
Developing novel nano- based platforms for targeted delivery and improved therapeutic outcomes.
DRUG
REPURPOSING
Identifying new therapeutic applications for existing compounds to accelerate treatment options.
OUR DEVELOPMENT ROADMAP
From Discovery to Translation
Single-Cell Seq & Immunoprofiling
Prototype Development
In Vitro
Validation
Lead Selection & Optimization
Preclinical Validation
IND-Enabling Development
Completed/Active
Current Focus
Upcoming
Future
OUR MILESTONES
Building Valere Therapeutics
JUL 2025
SEP 2025
2025
DEC 2025
31 AUG 2026
LEAP
2026
NEXT
Jameel Deep Tech Initiative
Semifinalist
Selected among top deep-tech ventures and advanced to the semifinal round.
DeepTech Geeks Final Pitching Round
Advanced to the final pitching round of the DeepTech Geeks program.
SAR 90K Internal Funding
Secured SAR 90,000 in internal funding to support early-stage R&D and development.
Saudi Biotech Accelerator
Selected Participant Selected to join the Saudi Biotech Accelerator to advance our science and build our commercialization strategy.
LEAP 2026
Startup Exhibitor
We will be at LEAP 2026 as a startup exhibitor to connect with investors and explore collaborations.
Prototype Development & Validation
Advancing our prototypes through development and validation while building strategic partnerships to accelerate our technology.
Meet Valere Therapeutics at
LEAP 2026
We are looking to connect with investors, biotechnology partners, research institutions and collaborators who share our ambition to advance next-generation immunotherapies.
31 August 2026
Riyadh, Saudi Arabia
Startup Exhibitor
Advancing Immunotherapy
with Local Impact and Global Ambition.
bottom of page